Hedge fund Elliot Management Corp. has made an unsolicited bid for Athenahealth Inc. (ATHN) of $160 per share, or an estimated total
Categories
Other Industries
Blackstone’s buying spree continues with Gramercy deal
Blackstone today announced that it's buying Gramercy Property Trust (GPT) for $7.6 billion. The private equity (PE) firm has agreed to pay
Ionis Pharmaceuticals reports first quarter 2018 results
Ionis Pharmaceuticals Inc. (IONS) reported total revenues of $144 million for the first quarter of 2018, an increase of 25% from the
Celgene posts upbeat Q1 results on multiple myeloma drug
U.S. biotechnology company Celgene (CELG) reported better-than-expected first quarter results, as its flagship drug for multiple myeloma continued to increase in new
DowDuPont posts upbeat Q1 results on higher pricing and demand
DowDuPont (DWDP) reported upbeat first-quarter results, as increased product pricing and demand for packaging, paint and other materials outweighed weak agriculture business.
US generic drug market throttles Teva Pharmaceuticals as revenue slips
Teva Pharmaceuticals Industries Ltd. (TEVA) reported a decrease of 10% in revenues to $5.1 billion for the first quarter of 2018 compared
3D Systems sees quarterly revenue growth as competitors fall behind
3D Systems Corporation (DDD) reported a revenue growth of 6% to $165.9 million during the first quarter of 2018 compared to the
Gibson trying to play a different tune post bankruptcy
Guitar-maker Gibson on Tuesday filed for bankruptcy as debt woes continue to haunt the firm. As part of the restructuring plan, it
Delta Air Lines traffic and capacity rises in April
Delta Air Lines (DAL) reported some impressive growth in both traffic and capacity for the month of April. However, the airline stock
Chesapeake misses on revenue expectations; reports higher earnings
Petroleum and natural gas exploration and production company Chesapeake Energy (CHK) reported higher quarterly earnings today that surpassed analysts' expectations, as it
Retail pharmacy lifts CVS Health in the first quarter
CVS Health Corporation (CVS) reported an increase of 2.6% in revenues to around $45.7 billion for the first quarter of 2018 compared
Gilead Sciences stock slips after Q1 results miss consensus
Gilead Sciences (GILD) reported a 43% dip in earnings for the first quarter due to lower product sales and prescription trends. Higher
Twitter signs ad and live content deal with Disney’s ESPN
Twitter (TWTR) shares witnessed some strong upward movement after the company announced a deal with Disney’s (DIS) ESPN. The stock was up
Merck reports strong first quarter sales helped by Keytruda
Pharma giant Merck (MRK) reported a 6% increase in worldwide sales to $10 billion for the first quarter of 2018 compared to
Shares fall as Pfizer misses revenue expectations
Drug giant Pfizer Inc. (PFE) posted a 1% improvement in revenues of $12.9 billion for the first quarter of 2018. Reported net
Transocean posts bigger than expected Q1 loss; revenue down 10%
Transocean Ltd (RIG) continued its losing streak that began nearly a year ago and posted a wider than expected loss in the
Marathon agrees to buy Andeavor for $23.3 billion
The M&A scenario seems to have picked up in the US with the proposed merger between T-Mobile (TMUS) and Sprint (S). Adding
Airline companies stare at a burning issue as fuel prices skyrocket
The aviation industry invariably falls on the receiving end whenever there is a financial crisis or geopolitical issue. At a time when
Botox, Juvederm sales lift Allergan in first quarter
Allergan plc (AGN) reported a 3% improvement in revenues to $3.7 billion for the first quarter of 2018 compared to the prior
Phillips 66 reports first quarter 2018 results
Energy company Phillips 66 (PSX) reported net earnings of $524 million, or $1.07 per share, for the first quarter of 2018, down
Higher volume, prices fuel Chevron’s earnings beat; Stock gains in early trading
Chevron Corp. (CVX) Friday reported robust earnings growth for the first quarter even as crude oil prices continue to spike. Earnings topped